PBH
Prestige Consumer Healthcare Inc. NYSE Listed Feb 10, 2005$46.97
+1.80%
vs $46.14
Mkt Cap $2.4B
52w Low $45.44
3.9% of range
52w High $84.67
50d MA $51.58
200d MA $60.06
P/E (TTM)
10.9x
EV/EBITDA
9.0x
P/B
1.3x
Debt/Equity
0.6x
ROE
10.9%
P/FCF
9.7x
RSI (14)
47.60
ATR (14)
$1.77
Beta
0.47
50d MA
$51.58
200d MA
$60.06
Avg Volume
824.6K
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
660 White Plains Road · Tarrytown, NY 10591 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 5, 2026 | AMC | 1.16 | 1.14 | -1.7% | 65.55 | +0.2% | +1.2% | -1.5% | +1.2% | -0.2% | +1.5% | — |
| Nov 6, 2025 | AMC | 0.97 | 1.07 | +10.3% | 61.36 | -0.1% | -2.3% | +0.9% | +0.2% | -0.1% | -0.9% | — |
| Aug 7, 2025 | AMC | 1.01 | 0.95 | -5.9% | 67.61 | -0.4% | -3.0% | -2.6% | +2.2% | +1.7% | -2.8% | — |
| May 8, 2025 | AMC | 1.30 | 1.32 | +1.5% | 87.04 | -1.1% | +0.3% | +0.8% | -1.2% | -1.8% | +2.0% | — |
| Feb 6, 2025 | AMC | 1.16 | 1.22 | +5.2% | 87.35 | -0.2% | -0.4% | +0.2% | -1.4% | -2.0% | +1.7% | — |
| Nov 7, 2024 | AMC | 1.08 | 1.09 | +0.9% | 80.09 | +0.4% | +0.3% | +1.7% | -0.1% | +0.8% | +0.6% | — |
| Aug 8, 2024 | AMC | 0.86 | 0.90 | +4.7% | 66.84 | +0.2% | -0.9% | -1.5% | +3.1% | +0.3% | +1.8% | — |
| May 14, 2024 | AMC | 1.14 | 0.98 | -14.0% | 71.47 | -10.7% | -7.0% | -2.2% | -0.5% | +0.1% | +0.5% | — |
| Feb 8, 2024 | AMC | 1.04 | 1.06 | +1.9% | 68.80 | +0.3% | -0.2% | -1.0% | -2.0% | +1.7% | +1.6% | — |
| Nov 2, 2023 | AMC | 1.07 | 1.07 | +0.0% | 59.17 | +1.4% | +0.7% | +0.2% | +0.3% | -1.4% | -2.2% | — |
| Aug 3, 2023 | AMC | 1.01 | 1.06 | +5.0% | 66.52 | -1.0% | +1.2% | +1.4% | -5.9% | +1.2% | -1.3% | — |
| May 4, 2023 | AMC | 1.04 | 1.07 | +2.9% | 62.02 | +0.1% | -2.0% | -2.1% | -1.8% | +0.5% | -0.6% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 14 | Oppenheimer | Downgrade | Outperform → Perform | — | $51.81 | $48.06 | -7.2% | -11.3% | +1.8% | -0.3% | -0.3% | +1.6% |
| Feb 2 | Jefferies | Maintains | Hold → Hold | — | $64.47 | $64.15 | -0.5% | +1.5% | -1.5% | +4.0% | -2.2% | +1.2% |
| Nov 7 | Canaccord Genuity | Maintains | Buy → Buy | — | $61.36 | $61.28 | -0.1% | -2.3% | +0.9% | +0.2% | -0.1% | -0.9% |
| Oct 27 | Jefferies | Maintains | Hold → Hold | — | $62.23 | $61.98 | -0.4% | +0.3% | -0.6% | -2.1% | -0.7% | +0.5% |
| Oct 21 | Oppenheimer | Maintains | Outperform → Outperform | — | $62.18 | $61.78 | -0.6% | +0.5% | +1.4% | -1.2% | -0.6% | +0.3% |
| Aug 8 | Canaccord Genuity | Maintains | Buy → Buy | — | $67.61 | $67.31 | -0.4% | -3.0% | -2.6% | +2.2% | +1.7% | -2.8% |
| Mar 21 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $84.36 | $83.71 | -0.8% | -0.2% | +1.4% | -0.4% | +0.0% | +1.2% |
| Feb 13 | Oppenheimer | Maintains | Outperform → Outperform | — | $84.21 | $85.44 | +1.5% | +1.7% | +0.4% | -0.9% | -0.4% | -0.1% |
| Feb 7 | DA Davidson | Maintains | Buy → Buy | — | $87.35 | $87.15 | -0.2% | -0.4% | +0.2% | -1.4% | -2.0% | +1.7% |
| Feb 7 | Canaccord Genuity | Maintains | Buy → Buy | — | $87.35 | $87.15 | -0.2% | -0.4% | +0.2% | -1.4% | -2.0% | +1.7% |
| Nov 11 | DA Davidson | Maintains | Buy → Buy | — | $80.37 | $81.43 | +1.3% | +1.7% | -0.1% | +0.8% | +0.6% | -0.5% |
| Aug 28 | DA Davidson | Maintains | Buy → Buy | — | $72.61 | $72.73 | +0.2% | +1.5% | +0.4% | +0.9% | -0.7% | +1.9% |
| Aug 9 | Canaccord Genuity | Maintains | Buy → Buy | — | $66.84 | $66.97 | +0.2% | -0.9% | -1.5% | +3.1% | +0.3% | +1.8% |
| Aug 9 | DA Davidson | Maintains | Buy → Buy | — | $66.84 | $66.97 | +0.2% | -0.9% | -1.5% | +3.1% | +0.3% | +1.8% |
| Jun 21 | DA Davidson | Upgrade | Neutral → Buy | — | $65.28 | $66.61 | +2.0% | +6.3% | -1.3% | +0.9% | -0.3% | +1.0% |
| May 21 | Canaccord Genuity | Maintains | Buy → Buy | — | $64.70 | $64.70 | +0.0% | +0.5% | -0.5% | -1.4% | +0.2% | -1.2% |
| May 16 | DA Davidson | Maintains | Neutral → Neutral | — | $66.46 | $66.11 | -0.5% | -2.2% | -0.5% | +0.1% | +0.5% | -0.5% |
| Jun 26 | DA Davidson | Maintains | Neutral → Neutral | — | $57.21 | $57.17 | -0.1% | +1.2% | +0.4% | -0.4% | +1.8% | +0.8% |
| May 8 | DA Davidson | Maintains | Neutral → Neutral | — | $60.76 | $60.61 | -0.2% | -2.1% | -1.8% | +0.5% | -0.6% | +1.1% |
| Mar 17 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $61.78 | $61.51 | -0.4% | -0.8% | +0.6% | -0.4% | -0.7% | +0.0% |
| Feb 17 | Oppenheimer | Maintains | Outperform → Outperform | — | $60.76 | $61.41 | +1.1% | +1.2% | -0.5% | -0.5% | +1.5% | -1.4% |
| Jan 13 | Oppenheimer | Maintains | Outperform → Outperform | — | $65.77 | $66.85 | +1.6% | +1.3% | -1.2% | -0.0% | +1.0% | +0.4% |
| Nov 17 | Canaccord Genuity | Maintains | Buy → Buy | — | $58.35 | $58.58 | +0.4% | +0.2% | +2.2% | -0.3% | +2.2% | -1.8% |
| May 10 | Jefferies | Upgrade | Hold → Buy | — | $57.45 | $58.68 | +2.1% | +0.2% | -3.4% | +1.2% | +0.9% | +0.4% |
| May 9 | DA Davidson | Maintains | Neutral → Neutral | — | $54.88 | $55.16 | +0.5% | +4.7% | +0.2% | -3.4% | +1.2% | +0.9% |
| May 9 | Oppenheimer | Upgrade | Perform → Outperform | — | $54.88 | $55.16 | +0.5% | +4.7% | +0.2% | -3.4% | +1.2% | +0.9% |
| Nov 15 | DA Davidson | Maintains | Neutral → Neutral | — | $62.74 | $62.74 | +0.0% | -2.3% | +0.1% | -0.6% | -1.2% | -3.3% |
| Aug 6 | DA Davidson | Maintains | Neutral → Neutral | — | $56.47 | $57.00 | +0.9% | +4.1% | -0.6% | +2.2% | +1.4% | -1.9% |
| May 28 | DA Davidson | Maintains | Neutral → Neutral | — | $50.30 | $50.72 | +0.8% | -0.9% | +0.1% | +0.0% | +0.8% | -0.7% |
| May 10 | DA Davidson | Maintains | Neutral → Neutral | — | $46.10 | $46.75 | +1.4% | +1.6% | +0.6% | -1.1% | +4.3% | -0.2% |
| Nov 6 | DA Davidson | Maintains | Neutral → Neutral | — | $33.68 | $33.70 | +0.1% | -1.9% | +3.2% | +3.5% | -0.1% | +0.0% |
| Aug 7 | DA Davidson | Downgrade | Buy → Neutral | — | $40.79 | $39.81 | -2.4% | -2.1% | -0.9% | -3.6% | -1.0% | -0.1% |
| Mar 26 | Jefferies | Upgrade | Hold → Buy | — | $30.74 | $33.00 | +7.4% | +14.3% | +3.6% | +2.1% | -1.3% | +1.3% |
| Mar 24 | Oppenheimer | Maintains | Perform → Perform | — | $29.50 | $30.98 | +5.0% | +9.7% | -5.0% | +14.3% | +3.6% | +2.1% |
| Mar 19 | DA Davidson | Upgrade | Neutral → Buy | — | $30.00 | $30.60 | +2.0% | +4.4% | -3.6% | -2.3% | +9.7% | -5.0% |
| Nov 4 | DA Davidson | Maintains | Neutral → Neutral | — | $36.93 | $37.41 | +1.3% | +3.7% | -1.1% | -0.7% | +1.2% | +0.4% |
| Jan 15 | Raymond James | Downgrade | Outperform → Market Perform | — | $28.53 | $26.36 | -7.6% | -1.5% | +2.0% | -1.0% | -1.7% | -1.4% |
| May 5 | B. Riley FBR | Maintains | Buy → Buy | — | — | — | — | — | — | — | — | — |
| Feb 5 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $35.83 | $35.50 | -0.9% | -0.8% | +4.9% | -1.0% | -4.2% | -4.5% |
| Feb 5 | KeyBanc | Maintains | Overweight → Overweight | — | $35.83 | $35.50 | -0.9% | -0.8% | +4.9% | -1.0% | -4.2% | -4.5% |
| Feb 5 | DA Davidson | Downgrade | Buy → Neutral | — | $35.83 | $35.50 | -0.9% | -0.8% | +4.9% | -1.0% | -4.2% | -4.5% |
| Dec 4 | William Blair | Upgrade | Market Perform → Outperform | — | $44.56 | $46.79 | +5.0% | +7.0% | -1.8% | +0.1% | -0.8% | +0.6% |
| Nov 15 | BMO Capital | Upgrade | Market Perform → Outperform | — | $40.67 | $40.70 | +0.1% | +0.0% | +2.5% | +1.4% | +0.6% | +0.4% |
| Nov 3 | Jefferies | Maintains | Hold → Hold | — | $43.76 | $43.50 | -0.6% | -1.8% | +0.2% | -1.3% | -2.3% | -1.3% |
| May 22 | Raymond James | Upgrade | Market Perform → Outperform | — | $49.39 | $51.66 | +4.6% | +1.6% | -0.3% | -0.0% | +0.4% | -0.7% |
| May 9 | DA Davidson | Maintains | Buy → Buy | — | $56.11 | $56.80 | +1.2% | +2.0% | -0.5% | -6.0% | -2.5% | -1.9% |
| Nov 17 | Gabelli & Co. | Maintains | Buy → Buy | — | $49.83 | $50.67 | +1.7% | +1.0% | -2.4% | -0.2% | -0.1% | +0.1% |
| Mar 7 | KeyBanc | Maintains | Overweight → Overweight | — | $51.28 | $51.08 | -0.4% | +0.8% | -0.6% | +0.6% | -0.3% | +2.7% |
| Feb 5 | Piper Sandler | Maintains | Overweight → Overweight | — | $49.25 | $49.80 | +1.1% | -2.4% | +1.1% | +0.3% | -2.3% | -1.5% |
| Jan 25 | Jefferies | Maintains | Underperform → Underperform | — | $47.26 | $46.95 | -0.7% | -1.8% | +0.8% | -0.4% | -2.0% | +2.2% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| May 11, 2026 | Zerillo JeffreyOff | Senior VP Operations | Sell | 351 | $52.28 | $18K | 41,810 | +2.78% | -0.34% |
| May 7, 2026 | Zerillo JeffreyOff | Senior VP Operations | Sell | 305 | $54.36 | $17K | 42,161 | -0.47% | -0.32% |
| May 5, 2026 | Zerillo JeffreyOff | Senior VP Operations | Sell | 1,207 | $54.99 | $66K | 42,820 | -3.76% | -11.35% |
| May 5, 2026 | Zerillo JeffreyOff | Senior VP Operations | Sell | 346 | $55.32 | $19K | 44,334 | +0.52% | +2.52% |
8-K · 2.01
!!! Very High
Prestige Consumer Healthcare Inc. -- 8-K 2.01: Acquisition Completed
Jun 16
8-K · 1.01
!! High
Unknown — 8-K 1.01: Material Agreement
Prestige Consumer Healthcare's new agreement with Foundation Consumer Brands could expand distribution channels or enable product line extensions, potentially driving revenue growth and improving competitive positioning in the consumer health sector.
Mar 20
8-K · 7.01
! Medium
Prestige Consumer Healthcare Inc. -- 8-K 7.01: Regulation FD Disclosure
Prestige Consumer Healthcare (PBH) disclosed Q4 2025 earnings presentation materials to investors, indicating management expects to use these slides in upcoming investor communications and analyst meetings.
Feb 5
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Ariel Investments, Llc | 4,274,326 | $253M | Added | Mar 2026 |
| 2 | Vanguard Portfolio Management Llc | 2,803,828 | $166M | New | Mar 2026 |
| 3 | Morgan Stanley | 2,405,854 | $148M | Added | Dec 2025 |
| 4 | Vanguard Capital Management Llc | 2,092,993 | $124M | New | Mar 2026 |
| 5 | Allspring Global Investments Holdings, Llc | 1,558,104 | $90M | Reduced | Mar 2026 |
| 6 | Westwood Holdings Group Inc | 1,179,636 | $73M | Added | Dec 2025 |
| 7 | Capital Research Global Investors | 894,679 | $53M | Added | Mar 2026 |
| 8 | Northern Trust Corp | 750,305 | $44M | Added | Mar 2026 |
| 9 | Boston Trust Walden Corp | 643,340 | $38M | Reduced | Mar 2026 |
| 10 | Invesco Ltd. | 595,998 | $35M | Added | Mar 2026 |
| 11 | Nordea Investment Management Ab | 599,375 | $35M | Reduced | Mar 2026 |
| 12 | Raymond James Financial Inc | 556,460 | $33M | Reduced | Mar 2026 |
| 13 | Bank Of America Corp /de/ | 547,442 | $32M | Reduced | Mar 2026 |
| 14 | Rice Hall James & Associates, Llc | 500,600 | $31M | Reduced | Dec 2025 |
| 15 | Congress Asset Management Co | 450,200 | $27M | Added | Mar 2026 |
| 16 | Ubs Group Ag | 392,209 | $23M | Reduced | Mar 2026 |
| 17 | D.e. Shaw & Co | 381,033 | $23M | Reduced | Mar 2026 |
| 18 | Leeward Investments, Llc - Ma | 376,808 | $22M | Reduced | Mar 2026 |
| 19 | Bank Of New York Mellon Corp | 311,341 | $18M | Reduced | Mar 2026 |
| 20 | Wells Fargo & Company/mn | 300,133 | $18M | New | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$2.35B
Enterprise Value
$3.25B
P/E (TTM)
10.95x
Forward P/E
9.76x
PEG Ratio
7.62x
P/B
1.27x
P/S
2.07x
P/FCF
9.67x
EV/EBITDA
8.97x
Shares Out
50.1M
Financials (TTM)
Revenue
$1.14B
Net Income
$214.6M
EBITDA
$362.0M
Free Cash Flow
$243.3M
Op Cash Flow
$251.5M
EPS Basic
$4.32
EPS Diluted
$4.29
EPS Forward
$4.81
Gross Margin
55.8%
Op Margin
29.6%
Net Margin
18.9%
Balance Sheet
Total Assets
$3.40B
Total Liab.
$1.57B
Total Equity
$1.83B
Cash
$97.9M
LT Debt
$992.4M
Book Value/Sh
$36.92
Debt/Equity
0.57x
Current Ratio
4.20
Quick Ratio
2.82
Returns & Growth
ROE
10.9%
ROA
5.7%
ROIC
7.7%
Rev Growth YoY
+1.1%
EPS Growth YoY
+2.6%
Price Returns
2W
+3.5%
1M
-15.6%
3M
-31.4%
6M
-20.2%
12M
-44.5%
Technicals
52W High
$84.67
52W Low
$45.44
50d MA
$51.58
200d MA
$60.06
RSI (14)
47.60
ATR (14)
$1.77
Beta
0.47
Avg Volume
825K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
Dec 27, 2013
Analyst Price Targets
Consensus
$66.00
High
$66.00
Low
$66.00
Median
$66.00
Data updated apr 26, 2026 6:49pm
· Source: financialmodelingprep.com